Your browser doesn't support javascript.
loading
A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategies.
Sharman, Jeffrey P; Biondo, Juliana M L; Boyer, Michelle; Fischer, Kirsten; Hallek, Michael; Jiang, Dingfeng; Kater, Arnon P; Porro Lurà, Michele; Wierda, William G.
Afiliación
  • Sharman JP; Department of Medical Oncology Willamette Valley Cancer Institute and Research Center/US Oncology Research Eugene Oregon USA.
  • Biondo JML; Genentech, Inc. South San Francisco California USA.
  • Boyer M; Roche Products Limited Welwyn Garden City UK.
  • Fischer K; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, German CLL Study Group, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf Germany.
  • Hallek M; University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, German CLL Study Group, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf Germany.
  • Jiang D; AbbVie North Chicago Illinois USA.
  • Kater AP; Department of Hematology Cancer Center Amsterdam Lymphoma and Myeloma Center Amsterdam Amsterdam University Medical Centers Amsterdam the Netherlands.
  • Porro Lurà M; F. Hoffmann-La Roche Ltd Basel Switzerland.
  • Wierda WG; Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA.
EJHaem ; 3(2): 492-506, 2022 May.
Article en En | MEDLINE | ID: mdl-35846043

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: EJHaem Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: EJHaem Año: 2022 Tipo del documento: Article
...